Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study

被引：0
|
作者：
Tomohiro Kaneko
Sakiko Miyazaki
Azusa Kurita
Ryoko Morimoto
Shun Tsuchiya
Naoki Watanabe
Tomoiku Takaku
Norio Komatsu
Tohru Minamino
机构：
[1] Juntendo University Graduate School of Medicine,Department of Cardiovascular Biology and Medicine
[2] Juntendo University Graduate School of Medicine,Department of Hematology
来源：
Cardio-Oncology | / 9卷
关键词：
Tyrosine kinase inhibitors; Chronic myeloid leukemia; Endothelial dysfunction; Uric acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Second Tyrosine Kinase Inhibitor Discontinuation Attempt in Patients With Chronic Myeloid Leukemia
    Legros, Laurence
    Nicolini, Franck E.
    Etienne, Gabriel
    Rousselot, Philippe
    Rea, Delphine
    Giraudier, Stephane
    Guerci-Bresler, Agnes
    Huguet, Francoise
    Gardembas, Martine
    Escoffre, Martine
    Ianotto, Jean-Christophe
    Noel, Marie-Pierre
    Varet, Bruno R.
    Pagliardini, Thomas
    Touitou, Irit
    Morisset, Stephane
    Mahon, Francois-Xavier
    CANCER, 2017, 123 (22) : 4403 - 4410
  • [42] The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
    Aribi, Ahmed
    Kantarjian, Hagop
    Koller, Charles
    Thomas, Deborah
    Faderl, Stefan
    Gareia-Manero, Guillermo
    Cortes, Jorge
    CANCER, 2008, 113 (06) : 1338 - 1343
  • [43] Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia
    Cheng, Fang
    Cui, Zheng
    Li, Qiang
    Wang, Liu
    Li, Weiming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [44] Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia
    Seo, Hee Yeon
    Ko, Tae Hwa
    Hyun, Shin Young
    Song, Hyebin
    Lim, Seung Taek
    Shim, Kwang Yong
    Lee, Jong In
    Kong, Jee Hyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11): : 735 - +
  • [45] Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
    Russo, Domenico
    Malagola, Michele
    Skert, Cristina
    Fili, Carla
    Bergonzi, Cesare
    Cancelli, Valeria
    Cattina, Federica
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 755 - 767
  • [46] Endothelial Function as Measured by Peripheral Arterial Tonometry Increases during Pubertal Advancement
    Bhangoo, Amrit
    Sinha, Sunil
    Rosenbaum, Michael
    Shelov, Steven
    Ten, Svetlana
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (04): : 226 - 233
  • [47] Supporting Adherence to Tyrosine Kinase Inhibitor (TKI) Therapy Among Patients with Chronic Myeloid Leukemia (CML)
    Nodzon, Lisa
    Tinsley-Vance, Sara
    BLOOD, 2017, 130
  • [48] Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
    Hanna L. M. Rajala
    Mohamed El Missiry
    Anniina Ruusila
    Perttu Koskenvesa
    Tim H. Brümmendorf
    Bjorn T. Gjertsen
    Jeroen Janssen
    Kourosh Lotfi
    Berit Markevärn
    Ulla Olsson-Strömberg
    Leif Stenke
    Jesper Stentoft
    Johan Richter
    Henrik Hjorth-Hansen
    Anna Kreutzman
    Satu Mustjoki
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1543 - 1554
  • [49] Predicting Outcomes in Patients With Chronic Myeloid Leukemia at Any Time During Tyrosine Kinase Inhibitor Therapy
    Quintas-Cardama, Alfonso
    Choi, Sangbum
    Kantarjian, Hagop
    Jabbour, Elias
    Huang, Xuelin
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (04): : 327 - 334
  • [50] Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
    Eskazan, Ahmet Emre
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2516 - 2517
12345